Cambridge Cognition is pleased to announce its attendance at the AAIC Annual Conference.
Visit us on Booth #808 to see the latest cognitive assessment technology in Alzheimer’s research and speak to our cognition and technology experts.
We will also be presenting new data on the use of new digital health technologies such as voice-based cognitive assessments and using computerised cognitive tests to predict clinical diagnosis.
Speak to us at AAIC to learn more about digital health solutions for:
- Patient recruitment in Alzheimer’s disease trials
- Identifying and assessing patients for early signs of MCI
- Measuring treatment efficacy
- Demonstrating real-world efficacy to patients, clinicians & payers
Our conference highlights
Sunday 16th July
9:30 am - 4:15 pm
Poster: Paired Associates Learning: Adding Sensitivity By Measuring Reaction Times. Francesca Cormack, Director of Research and Innovation.
9:30 am - 4:15 pm
Poster: Higher aerobic fitness improves performance on cognitive tasks and measures of quality of life: A cross-sectional study of young and old individuals. Claire Burley, University of Birmingham
Monday 17th July
4:15 pm - 5:45 pm
Oral: Predicting clinical diagnosis from patterns of impaired performance on computerised cognitive testing in a mixed neurological sample. Francesca Cormack, Director of Research and Innovation
Wednesday 19th July
9:30 pm - 4:15 pm
Poster: Pre-screening for episodic memory deficits can enrich for eligible subjects in early Alzheimer’s disease clinical trials. Rosemary Abbott, Principal Statistical Analyst
They will also be showcasing Cambridge Cognition's latest products enabling researchers, biotech and pharmaceutical companies to deliver success in clinical trials.
Join our team for one of the sessions above or find us on booth 808 to see the latest in neurotechnology.